Astron Secures ISO 9001:2015, demonstrates its commitment to quality

Rate this item
(0 votes)
Published in Healthcare & Insurance Thursday, 03 April 2025 07:56

Astron

Businesscafe - In a significant move towards enhancing product quality and safety, Astron Limited has successfully secured the ISO 9001:2015 Quality Management Certification across all its manufacturing operations in 2025.

This certification marks yet another milestone in Astron's commitment to quality assurance and operational excellence.


Quality is a cornerstone to Astron's success.


The Company has expanded its product lines innovatively, now including a Pet Care Range alongside its established offerings in General Pharmaceuticals, Antibiotics including penicillins, Vitamins, Nutritional Supplements, Animal Health Feed supplements and Herbal Products.


The Company holds several internationally recognized certifications, including GMP certification from the National Medicines Regulatory Authority of Sri Lanka, ISO22000:2018, HACCP and GMP for nutritional supplement manufacturing, CAC/RCP 54-2004 – Code of Practice on Good Animal Feeding and SLS 1505:2015 – Code of Practice for Good Animal Feed Production & Feedings and ISO14001:2015 Environmental Management System Certification from SLSI, GMP for Herbal Product Manufacturing from SGS.


Additionally, their mechanical, chemical and microbiology testing laboratories are accredited for ISO 17025:2017.


The integration of ISO 9001:2015 with these standards provides a comprehensive framework for a centralized quality management system, aiding in regulatory approvals for exports and high-quality standards for its manufactured products.


With over six decades of experience, Astron takes pride in its continuously expanding locally manufactured product portfolio, consistently striving to exceed customer expectations.


The Company credits its operational excellence, strong ethics and rewarding work culture as key factors to its success.


With consistent commitment to quality and customer satisfaction, Astron Limited is poised to continue its growth trajectory and maintain its reputation as a leader in the local manufacturing of pharmaceuticals and health care industry.


Photo Caption : From Left : Representing Astron Limited Mr Kasun Wijekoon (QA Manager); Dr Malindra Badaturuge (Director Compliance & Technical); Mr Johann De Zilwa (CEO); Dr Ross De Zilwa (Managing Director), Representing SLSI Director General – Dr (Mrs) Siddhika Senarath; Mrs S U Narangoda (Deputy Director Generals) Mrs M B D Neelakanthi (Deputy Director General); Mr L H Karaliyadda (Senior Deputy Director)

Read 63 times Last modified on Thursday, 03 April 2025 08:11